Introduction
Model Details
Phenotypic Evaluation
Applications
Study Examples
Introduction
Diabetic retinopathy (DR) is a common microvascular complication of diabetes and a leading cause of vision loss in working-age adults. Chronic hyperglycemia drives progressive retinal damage through oxidative stress, inflammation, vascular dysfunction, and neurodegeneration. Key pathological features include retinal vascular leakage, capillary degeneration, basement membrane changes, neuronal cell loss, photoreceptor dysfunction, and, in advanced disease, pathological neovascularization. Clinically, patients may present with blurred vision, impaired color or contrast sensitivity, floaters, macular edema, or severe vision loss. DR affects both type 1 and type 2 diabetic populations, with risk increasing with disease duration and poor glycemic control.
Current management includes glycemic control, laser photocoagulation, intravitreal anti-VEGF therapy, corticosteroids, and vitrectomy in advanced cases. However, early retinal neurovascular injury, patient-to-patient variability, and limited predictive screening models remain important research challenges. Zebrafish models provide a practical in vivo system to study hyperglycemia-induced retinal changes, retinal vascular responses, visual dysfunction, and candidate drug activity in a vertebrate model suitable for imaging and medium-throughput screening.
Why Zebrafish?
- Direct Visualization: Transparent embryos enable direct visualization of retinal and vascular phenotypes.
- Conserved Architecture: Conserved retinal architecture supports translational assessment of neurovascular injury.
- Reporter Lines: Fluorescent vascular and neuronal reporter lines allow quantitative live imaging.
- Cost-Effective Screening: Small size and high fecundity support cost-effective compound screening.
- Flexible Timeframes: Larval and adult models cover both rapid screening and longer-term disease studies.
Available Zebrafish Disease Models
Zebrafish diabetic retinopathy research mainly uses hyperglycemia-induced models in adult fish and glucose-exposure models in larvae. These approaches reproduce key metabolic, vascular, inflammatory, and retinal phenotypes relevant to diabetic retinal injury.
| Model Name |
Induction Method |
Features |
| Adult Hyperglycemia-Induced Diabetic Retinopathy Model |
Adult zebrafish are exposed to repeated intraperitoneal glucose administration or sustained hyperglycemic conditions to induce prolonged elevation of blood glucose. Retinal tissues are subsequently evaluated for vascular, inflammatory, oxidative, and neuronal alterations. |
Established model for studying diabetes-associated retinal pathology and testing glucose-lowering or retinoprotective interventions. |
| Larval Glucose-Exposure Retinal Injury Model |
Developing zebrafish larvae are exposed to elevated glucose concentrations during defined developmental windows, producing sustained hyperglycemic stress and retinal vascular abnormalities. |
Suitable for rapid assessment of glucose-induced retinal injury, angiogenic responses, oxidative stress, and candidate protective compounds. |
| Diabetic Retinal Angiogenesis Model |
Hyperglycemic zebrafish are evaluated for diabetes-associated changes in retinal vessel formation and vascular remodeling using transgenic vascular reporter lines such as Tg(fli1:EGFP). |
Enables visualization and quantification of retinal vascular changes and is useful for investigating angiogenic mechanisms and anti-angiogenic therapies. |
Phenotypic Evaluation
Retinal Vascular Changes
- Vessel density
- Vessel branching
- Vascular leakage
Retinal Neuronal Injury
- RGC loss
- Retinal layer changes
- Neuronal apoptosis
Metabolic and Inflammatory Response
- Blood glucose
- Oxidative stress
- Inflammatory markers
Therapeutic Response
- Vascular normalization
- Retinal protection
- Disease phenotype improvement
Key Applications
- Drug Candidate Screening: Screening and ranking of anti-diabetic retinopathy drug candidates.
- Compound Evaluation: Evaluation of anti-angiogenic, neuroprotective, and antioxidant compounds.
- Mechanistic Studies: Mechanistic studies of hyperglycemia-induced retinal neurovascular injury.
- Ocular Safety Assessment: Assessment of retinal toxicity or ocular safety under diabetic conditions.
- Biomarker Discovery: Biomarker discovery using imaging, functional, and molecular endpoints.
Study Examples
The authors established a hyperglycemic adult zebrafish model using glucose exposure and evaluated retinal function and morphology. Electroretinography was used to assess visual responses, with particular attention to photoreceptor activity. The model showed a predominant impairment of cone photoreceptor function, consistent with early functional deficits reported in non-proliferative diabetic retinopathy.
Fig. 1. Hyperglycemia causes a cone-biased reduction in retinal electrophysiological responses (Alvarez, Y., Chen, K., et al. 2010).
Zebrafish embryos were exposed to high-glucose conditions during retinal development. The study examined retinal patterning, neuronal differentiation, and developmental eye phenotypes using molecular and imaging-based analyses. High glucose altered normal retinal organization and affected the distribution of retinal cell populations, indicating that hyperglycemia can directly interfere with early retinal development.
Fig. 2. High glucose exposure alters retinal patterning and cell differentiation during zebrafish embryogenesis (Singh, A., Castillo, et al., 2019).
Accelerate Diabetic Retinopathy Research with Zebrafish Models
Partner with us to design zebrafish diabetic retinopathy studies tailored to your program. We support model selection, protocol development, in vivo imaging, functional assays, molecular validation, and compound efficacy evaluation.
References
- Alvarez, Y., Chen, K., et al. Predominant cone photoreceptor dysfunction in a hyperglycaemic model of non-proliferative diabetic retinopathy. Disease Models & Mechanisms 3, 236–245 (2010).
- Singh, A., Castillo, et al. High glucose levels affect retinal patterning during zebrafish embryogenesis. Scientific Reports 9, 4121 (2019).
For research use only. Not intended for any clinical use.